Drugs for Foot Drop (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 8)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Bupivacaine |
Approved, Investigational |
Phase 3 |
|
2180-92-9, 38396-39-3 |
2474 |
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(±)-bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
15233-43-9
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
2180-92-9
38396-39-3
AB00053674
Abbott brand OF bupivacaine hydrochloride
AC1L1DRE
AC1Q5LX4
AC-2096
AH 250
AKOS001637202
Anekain
Anhydrous, bupivacaine
AR-1A0242
Astra brand OF bupivacaine hydrochloride
AstraZeneca brand OF bupivacaine hydrochloride
Aventis brand OF bupivacaine hydrochloride
Bio-0886
Bloqueina
BPBio1_000298
Braun brand OF bupivacaine hydrochloride
Braun, bupivacaina
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bucaine
Bucaine (TN)
Bupivacain janapharm
Bupivacain RPR
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaina braun
bupivacaine
Bupivacaine
Bupivacaine (INN)
Bupivacaine [INN:BAN]
Bupivacaine anhydrous
Bupivacaine carbonate
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL kit
Bupivacaine HCL KIT
Bupivacaine hydrochloride
Bupivacaine monohydrochloride, monohydrate
Bupivacaine Monohydrochloride, Monohydrate
Bupivacain-RPR
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
Buvacaina
C07529
C18H28N2O
Carbonate, bupivacaine
Carbostesin
cBupivacaine
CBupivacaine
CHEBI:3215
|
CHEMBL1098
CID2474
D07552
DB00297
DepoBupivacaine
DivK1c_000758
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
Dolanaest
DUR-843
EINECS 218-553-3
EINECS 253-911-2
HMS2090F12
Hydrochloride, bupivacaine
IDI1_000758
Inibsa brand OF bupivacaine hydrochloride
Janapharm, bupivacain
Jenapharm brand OF bupivacaine hydrochloride
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
Marcain
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MLS001361336
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Pisa brand OF bupivacaine hydrochloride
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SMR000058218
SPBio_001558
SPBio_002489
Spectrum_001524
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Strathmann brand OF bupivacaine hydrochloride
Svedocain sin vasoconstr
Transdur-Bupivacaine
UNII-Y8335394RO
Win 11318
Win 11318 HCl
|
|
2 |
|
Anesthetics, Local |
|
Phase 3 |
|
|
|
3 |
|
Anesthetics |
|
Phase 3 |
|
|
|
4 |
|
Azacitidine |
Approved, Investigational |
Phase 2 |
|
320-67-2 |
9444 |
Synonyms:
2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one
320-67-2
4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
4-amino-1-b-D-Ribofuranosyl-S-triazin-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one
4-Amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one
4-amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one
4-amino-1-beta-D-Ribofuranosyl-S-triazin-2(1H)-one
4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one
4-amino-1-beta-L-ribofuranosyl-1,3,5-triazin-2(1H)-one
4-amino-1-β-D-ribofuranosyl-S-triazin-2(1H)-one
5 Azacytidine
5 AZC
5-AC
5AzaC
5-AZAC
5-azacitidine
5-aza-CR
5-azacytidine
5-azacytidine, Mylosar, Ladakamycin, Vidaza, Azacitidine
5-AZCR
A 2385
A1287_SIGMA
A2385_SIGMA
AC1L1T1Y
Antibiotic U 18496
Azacitidina
Azacitidina [INN-Spanish]
Azacitidine
Azacitidine (JAN/USAN/INN)
Azacitidine [USAN:INN]
Azacitidinum
Azacitidinum [INN-Latin]
Azacytidine
BCBcMAP01_000083
BRN 0620461
BSPBio_003157
C11262
CCRIS 60
CHEBI:2038
CHEMBL1489
CID9444
cMAP_000082
CPD000857239
D001374
D03021
DB00928
DivK1c_000125
EINECS 206-280-2
EU-0100035
FT-0081170
HMS1921J22
HMS2092D08
HMS500G07
HSDB 6879
IDI1_000125
InChI=1/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
|
Jsp005945
KBio1_000125
KBio2_001742
KBio2_002556
KBio2_004310
KBio2_005124
KBio2_006878
KBio2_007692
KBio3_002657
KBio3_003034
KBioGR_001444
KBioGR_002556
KBioSS_001742
KBioSS_002565
Ladakamycin
Lopac0_000035
LS-1189
MLS001333121
MLS001333122
MLS002153249
MolMap_000062
mylo sar
Mylosar
NCGC00090851-01
NCGC00090851-02
NCGC00090851-03
NCGC00090851-04
NCGC00090851-08
NCGC00178234-01
NCI-C01569
NINDS_000125
NS-17
NSC 102816
NSC102816
NSC-102816
Pharmion brand OF azacitidine
Pharmion Brand of Azacitidine
pyrimidine antimetabolite: inhibits nucleic acid replication
S1782_Selleck
SAM002264595
SMR000857239
SPBio_000892
Spectrum_001262
SPECTRUM1502111
Spectrum2_000786
Spectrum3_001509
Spectrum4_000922
Spectrum5_001166
ST056940
s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- (8CI)
TL80073599
U 18496
U-18496
UNII-M801H13NRU
Vidaza
Vidaza (TN)
wr 183027
WR-183027
ZINC03861768
|
|
5 |
|
Ropivacaine |
Approved |
Early Phase 1 |
|
84057-95-4 |
71273 175805 |
Synonyms:
(-)-1-Propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
(-)-1-Propyl-2',6'-pipecoloxylidide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
(S)-(−)-1-propyl-2',6'-pipecoloxylidide
(S)-(-)-1-Propyl-2',6'-pipecoloxylidide
(S)-ropivacaine
1-Propyl-2',6'-pipecoloxylidide
84057-95-4
98717-15-8
AC1L41QM
AC1L41QN
BIDD:GT0203
C07532
C17H26N2O.HCl
CHEBI:8890
CHEMBL1077896
CID175804
CID175805
CPD000469137
D08490
I14-176
LEA 103
LEA-103
L-N-N-Propylpipecolate-2,6-xylidide
L-N-n-propylpipecolic acid-2,6-xylidide
|
L-N-N-Propylpipecolic acid-2,6-xylidide
LS-113954
MLS001401363
MolPort-003-983-292
Naropeine
Naropin
Naropin (TN)
NCGC00164597-01
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
ROPIVACAINE HCl
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
ropivacaine monohydrochloride,
ropivacaine monohydrochloride, (S)-isomer
Ropivacaine monohydrochloride, (S)-isomer
Ropivacainum
Ropivacainum [INN-Latin]
SAM001246524
SMR000469137
S-Ropivacaine
ST51051452
|
|
6 |
|
Levobupivacaine |
Approved, Investigational |
|
|
27262-47-1 |
92253 |
Synonyms:
(-)-bupivacaine
(-)-Bupivacaine
(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(S)-1-butyl-2',6'-pipecoloxylidide
(S)-1-Butyl-2',6'-pipecoloxylidide
(S)-bupivacaine
(S)-Bupivacaine
27262-47-1
27262-48-2
AC1L3NQM
BIDD:GT0471
C07887
C18H28N2O
CAS-18010-40-7
CHEBI:6149
Chirocaine
CID92253
D08116
DB01002
|
L-(-)-1-Butyl-2',6'-pipecoloxylidide
L-(-)-bupivacaine
L-(−)-bupivacaine
L(-)-Bupivacaine
L-(-)-Bupivacaine
Levobupivacaína
Levobupivacaine
Levobupivacaine (INN)
Levobupivacaine [INN:BAN]
Levobupivacaine hydrochloride
LS-109843
LS-187025
LS-187789
MolPort-004-959-713
NCGC00016733-01
NCGC00159482-02
Novabupi
Novabupi (TN)
|
|
7 |
|
Mepivacaine |
Approved, Vet_approved |
|
|
96-88-8 |
4062 |
Synonyms:
(+-)-1-Methyl-2',6'-pipecoloxylidide
1722-62-9 (mono-hydrochloride)
1-methyl-2',6'-pipecoloxylidide
1-Methyl-2',6'-pipecoloxylidide
1-METHYL-2',6'-PIPECOLOXYLIDIDE
22801-44-1
34811-66-0
3m Brand OF mepivacaine hydrochloride
5-22-01-00223 (Beilstein Handbook Reference)
96-88-8
Abbott brand OF mepivacaine hydrochloride
AC-15503
AC1L1HBV
Arestocaine HCL
Astra brand OF mepivacaine hydrochloride
AstraZeneca brand OF mepivacaine hydrochloride
Aventis brand OF mepivacaine hydrochloride
Braun brand OF mepivicaine hydrochloride
Braun, mepivacaina
BRD-A03216249-003-02-9
BRN 0211230
BSPBio_003297
C07528
Carbocain
Carbocaine
Carbocaïne
Carboplyin Dental
Carboplyin Dental (TN)
CHEBI:6759
CHEMBL1087
CID4062
Clarben brand OF mepivacaine hydrochloride
Curasan brand OF mepivacaine hydrochloride
D(-)-Mepivacaine
D08181
DB00961
Dentsply brand OF mepivacaine hydrochloride
DivK1c_006970
DL-Mepivacaine
D-mepivacaine
EINECS 202-543-0
Hexal brand OF mepivacaine hydrochloride
Hydrochloride, mepivacaine
I01-1864
Inibsa brand OF mepivacaine hydrochloride
Isocaine
Isocaine HCL
Isogaine
KBio1_001914
KBio2_001960
KBio2_004528
KBio2_007096
KBio3_002517
KBioGR_001092
|
KBioSS_001960
LS-109848
LS-109849
Meaverin
Mecain
Mepihexal
Mepivacain injektopas
Mepivacaina
Mepivacaina [INN-Spanish]
Mepivacaina braun
mepivacaine
Mepivacaine
Mepivacaine (INN)
Mepivacaine [INN:BAN]
Mepivacaine HCL
mepivacaine hydrochloride
Mepivacaine hydrochloride
Mepivacaine monohydrochloride
Mepivacain-injektopas
Mepivacainum
Mepivacainum [INN-Latin]
Mepivastesin
Mepivicaine
MolPort-005-935-383
Monohydrochloride, mepivacaine
N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
NCGC00089774-02
N-Methyl-2-pipecolic acid, 2,6-dimethylanilide
N-Methyl-2-pipecolic acid, 2,6-xylidide
N-Methylhexahydro-2-picolinic acid, 2,6-dimethylanilide
Novocol brand OF mepivacaine hydrochloride
Pascoe brand OF mepivacaine hydrochloride
Polocaine
Polocaine-Mpf
Polocaine-MPF
Sanofi brand OF mepivacaine hydrochloride
Scandicain
Scandicaine
Scandicane
Scandinibsa
Scandonest
Scandonest Plain
SPBio_001811
SpecPlus_000874
Spectrum_001480
Spectrum2_001656
Spectrum3_001629
Spectrum4_000596
Spectrum5_001354
S-Ropivacaine mesylate
S-Ropivacaine Mesylate
UNII-B6E06QE59J
|
|
8 |
|
Complement System Proteins |
|
|
|
|
|
Interventional clinical trials:
(show all 48)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Effects of Functional Electrical Stimulation on Gait in Children With Hemiplegic and Diplegic Cerebral Palsy |
Unknown status |
NCT02462018 |
Phase 4 |
|
2 |
Evaluation of the Safety and Performance of the NESS L300 Plus System |
Completed |
NCT01237860 |
Phase 3 |
|
3 |
Comparative Feasibility and Efficacy of a Five Compartment Technique Using 0.25% Bupivacaine vs a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka; a Single Blinded Randomized Controlled Study |
Terminated |
NCT03303794 |
Phase 3 |
Exparel;0.25% bupivacaine |
4 |
Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis |
Completed |
NCT00872053 |
Phase 1, Phase 2 |
|
5 |
An Open-Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy |
Completed |
NCT02346461 |
Phase 2 |
ManNAc;ManNAc |
6 |
Robot-assisted Ankle Rehabilitation for Multiple Sclerosis (Anklebot) |
Terminated |
NCT00765544 |
Phase 1, Phase 2 |
|
7 |
Pilot Feasibility Study of the Neurostep™ System in Subjects With Gait Disorder Secondary to CNS Lesion. |
Completed |
NCT00860210 |
Phase 1 |
|
8 |
The Orthotic Effect of Functional Electrical Stimulation to Treat Foot Drop in People With MS Under Walking Conditions Simulating Those in Daily Life |
Unknown status |
NCT03410498 |
|
|
9 |
Evaluation of Usability and Human Factors in the Novus System |
Unknown status |
NCT02738242 |
|
|
10 |
Pairing Functional Electrical Stimulation (FES) and Volitional Effort Training Promotes Neuroplasticity and Motor Gain |
Unknown status |
NCT02797886 |
|
|
11 |
Functional Electrical Stimulation to Treat Foot Drop in People With Multiple Sclerosis |
Completed |
NCT02123537 |
|
|
12 |
Targeted Lower Extremity Joint Training Effects on MS Gait Abnormalities |
Completed |
NCT00906737 |
|
|
13 |
Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop:Feasibility of Instrumented Gait Analysis in Clinical Practice. |
Completed |
NCT01914016 |
|
|
14 |
Adaptive Ankle Robot Control System to Reduce Foot-drop in Chronic Stroke |
Completed |
NCT02483676 |
|
|
15 |
Randomized Trial of the Innovative Neurotronics WalkAide Compared to Conventional Ankle-Foot Orthosis (AFO) in Stroke Patients (INSTRIDE) |
Completed |
NCT01087957 |
|
|
16 |
Identification of Responders to the FES Interventions in Stroke Population |
Completed |
NCT01952613 |
|
|
17 |
Functional Electrical Stimulation for Footdrop in Hemiparesis |
Completed |
NCT00148343 |
|
|
18 |
A Pilot Study to Assess the Effects of Using FES or AFO as an Assistive Mobility for Period of 12 Weeks for People With Multiple Sclerosis With Foot Drop |
Completed |
NCT01977287 |
|
|
19 |
Parameter Changes in Functional Electrical Stimulation |
Completed |
NCT03300986 |
|
|
20 |
A Three-Arm, Randomized Crossover Study Comparing the Innovative Neurotronics WalkAide™ System to Ankle-Foot Orthosis [AFO] |
Completed |
NCT00216320 |
|
|
21 |
The Therapeutic Effects of Peroneal Nerve Functional Electrical Stimulation for Lower Extremity in Patients With Sub-acute Post-stroke Hemiplegia A Randomized Controlled Study |
Completed |
NCT02898168 |
|
|
22 |
Functional Ambulation: Standard Treatment vs. Electronic Stimulation Therapy (FASTEST)Trial in Chronic Post-Stroke Subjects With Foot Drop |
Completed |
NCT01138995 |
|
|
23 |
Implanted Functional Electrical Stimulation of the Levators of the Ankle Versus Orthosis in the Treatment of Chronic Foot Neurological STEPPAGE-gait by Central Attack |
Completed |
NCT01415700 |
|
|
24 |
Clinical Effects of Peroneal Nerve Functional Electrical Stimulation (WalkAide[R]) for the Lower Extremities in Chronic Stroke Patients With Hemiplegia: A Multicenter, Prospective, Randomized Controlled Trial |
Completed |
NCT02897752 |
|
|
25 |
Effects of Two Different Types of Ankle Foot Orthoses on Gait Outcomes in Patients With Subacute Stroke. |
Completed |
NCT02693834 |
|
|
26 |
Clinical Study to Evaluate the Implantation of the ActiGait Drop Foot Stimulator System |
Completed |
NCT01116466 |
|
|
27 |
Do Patients Who Receive the IPACK and Adductor Canal Catheter Have Better Outcomes Than Patients Receiving the Adductor Canal Catheter Alone for Total Knee Replacements? |
Completed |
NCT03774966 |
Early Phase 1 |
|
28 |
Approach to Continuous Sciatic Nerve Block for Orthopedic Procedures in Day Surgery With Two Different Techniques |
Completed |
NCT02029404 |
|
|
29 |
The Evaluation of Dual Channel vs Single Channel FES for Dropfoot |
Completed |
NCT02494323 |
|
|
30 |
The Effect of Functional Electrical Stimulation Technology on Gait and Balance Performance in Children With Hemiplegic Cerebral Palsy |
Recruiting |
NCT04269798 |
|
|
31 |
Wearable Interactive Lower-limb Exoskeleton Robotic Device for Gait Training of Post-stroke Patients on Different Walking Conditions |
Recruiting |
NCT03184259 |
|
|
32 |
Brain Computer Interface - Functional Electrical Stimulation (BCI-FES) Therapy for Stroke Rehabilitation |
Recruiting |
NCT04279067 |
|
|
33 |
A Rigid Body Database on Human Movement |
Recruiting |
NCT00001252 |
|
|
34 |
Association Between the Transcranial Direct Current Stimulation (tDCS) and Foot Drop Stimulation (FDS) for Gait Rehabilitation After Stroke - A Randomized Clinical Trial |
Active, not recruiting |
NCT04077814 |
|
|
35 |
The Effect of Neuro-orthosis on Gait Performer in Chronic Post Stroke Subjects |
Active, not recruiting |
NCT04266899 |
|
|
36 |
Multi-pad Functional Electrical Stimulation for Droop Foot Treatment |
Enrolling by invitation |
NCT02729636 |
|
|
37 |
Walking Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project |
Not yet recruiting |
NCT03556709 |
|
|
38 |
Seated Ankle Robot for Foot Drop in Aging and Disabled Populations: A Demonstration Project |
Not yet recruiting |
NCT03530592 |
|
|
39 |
Comparison of Thermo-plastic Versus Carbon Foot Ankle Orthosis to Improve Gait and Reduce Fatigue in Post-stroke Patients: a Biomechanical and Neurophysiological Study |
Not yet recruiting |
NCT04323943 |
|
|
40 |
TREAT Foot Drop After Stroke With Ankle Robot |
Not yet recruiting |
NCT04137809 |
|
|
41 |
Influence of Whole Body Vibration on Neuromodulation of Ankle Muscles in Persons With SCI |
Not yet recruiting |
NCT04238013 |
|
|
42 |
Effects of Focal Muscle Vibration on Upper Limb Function in Subacute Post-stroke Patients |
Not yet recruiting |
NCT04289766 |
|
|
43 |
A Wearable for Post-stroke Rehabilitative Multi-muscle Stimulation Inspired by the Natural Organization of Neuromuscular Control |
Not yet recruiting |
NCT04154514 |
|
|
44 |
Use Of Autologous Stem Cell Use In Neurological Non-neoplastic Disorders And Disease |
Not yet recruiting |
NCT03297177 |
|
|
45 |
The Effects of Ankle Foot Orthoses on Gait Efficiency in Children With Acute Lymphoblastic Leukemia and Foot Drop |
Terminated |
NCT01001390 |
|
|
46 |
Prospective Randomized Controlled Trial Comparing Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer. |
Terminated |
NCT01751503 |
|
|
47 |
A Prospective, Randomized Study Comparing Continuous Femoral and Tibial Nerve Blocks vs. Continuous Femoral and Single Shot Sciatic Nerve Block in Total Knee Arthroplasties. |
Terminated |
NCT01680692 |
Early Phase 1 |
Ropivicaine |
48 |
Acute Nerve Decompression Versus Non-operative Treatment for Peroneal Nerve Palsy Following Primary Total Knee Arthroplasty |
Withdrawn |
NCT02856958 |
|
|
|